Dimethylfumarate for Psoriasis: Pronounced Effects on Lesional T-Cell Subsets, Epidermal Proliferation and Differentiation, but not on Natural Killer T Cells in Immunohistochemical Study

Author： Bovenschen H. Jorn   Langewouters Annechien M.G.   >  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.11, Iss.5, 2010-10, pp. : 343-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution

By Gendelman M.   Yassai M.   Tivol E.   Krueger A.   Gorski J.   Drobyski W.R.  

Biology of Blood and Marrow Transplantation, Vol. 9, Iss. 12, 2003-12 ,pp. : 742-752

Elsevier

Access to resources Recommend Favorite

Romidepsin in the Treatment of T-Cell Lymphoma†: Profile Report

By Yang Lily P.H.  

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 393-395

Adis International

Access to resources Recommend Favorite

Autologous T-Cell Vaccination for Multiple Sclerosis: A Perspective on Progress

By Vandenbark Arthur A.   Abulafia-Lapid Rivka  

BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. : 265-273

Adis International

Access to resources Recommend Favorite

Therapeutic Advances in Biological Response Modifiers in the Treatment of Cutaneous T-Cell Lymphoma

By Vittorio C.C.   Rook A.H.   French L.E.   Shapiro M.   Lehrer M.S.   Junkinshopkins J.M.  

BioDrugs, Vol. 15, Iss. 7, 2001-07 ,pp. : 431-437

Adis International

Access to resources Recommend Favorite

Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma

By Lyseng-Williamson Katherine A.   Yang Lily P.H.  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 67-71

Adis International

Access to resources Recommend Favorite